Unimicron should benefit from a persistent AI ABF substrate shortage and a shift toward higher-end products. Its projected share exceeds 30% as the market reaches $13bn/$18bn in 2027/28; added capacity is expected to lift ABF revenue 66%/90%. Higher-end ABF, mSAP and LPDDR lift margins, supporting 77% EPS CAGR. Initiate Buy with a NT$1,820 target at 30x 2027 earnings. x.com 

Ajinomoto, Nittobo, Ibiden and AT&S sit in an ABF substrate supply chain consolidated into near-monopolies, where the AI chip bottleneck keeps moving. Nvidia, Intel and AMD are prepaying for suppliers' factories, with Ibiden receiving over 90 billion yen; companies that size do not prepay unless out of options. Ajinomoto holds over 95% of the substrate film market, and Apple, Nvidia and Google are chasing Nittobo's glass fabric. A capex cycle ending in overcapacity is the risk. x.com  x.com 

IC substrates are Schmid's more relevant growth driver today because demand is already high and rising. Schmid customers Ibiden and Unimicron are expanding capacity with NVIDIA support; higher order intake supports the prospect of more equipment orders. Its balance sheet has improved, and the risk/reward looks attractive at current levels despite volatility. Glass substrates may take another one to two years to matter commercially. This is a personal assessment, not a buy recommendation. x.com  … Show more

Unimicron's profit leverage to rising ABF substrate prices should stay significantly positive and last longer than the market expects, even if customers absorb only part of the increases. As a high-end ABF leader, its high fixed costs and utilization leverage limit any squeeze from costlier T-glass. The T-glass bottleneck and long capacity cycles could extend the benefit for a year or two, and its high Nvidia and ASIC share adds pricing power, though execution on hikes and utilization matters. … Show more

Tight memory supply keeps the AI memory supplier trade in bill-of-materials names if it persists. The investor aleabitoreddit reports an SK hynix shortage outlook through 2030 and an operating-margin result near 80%. HBM allocation and average-selling-price guidance are the next tests; Korea has already priced the earnings print, so the next move depends on who locks capacity. x.com 

AMD and Nvidia face a growing capital burden from substrates without the benefit of foundry margin stacking. Each is committing $1 billion to the substrate ecosystem; AMD has also publicly committed $10 billion to its Taiwan supply chain, more than three times its Q2 net income. That capital is unavailable for R&D and product development, while their gross margins are flat or shrinking. Intel's gross margin is growing as customers prepay its foundry for substrates. x.com 

High-end ABF substrates are the next AI hardware bottleneck, giving Samsung Electro-Mechanics a large opportunity, per Meritz Securities. As AI accelerators scale, package areas are growing over 5x and pin counts up to 100x, while Ajinomoto, with over 90% of raw film supply, is maxed out and Ibiden runs at full capacity. Samsung Electro-Mechanics is rapidly expanding FC-BGA capacity to capture unallocated GPU demand, and Nvidia's 2028 Feynman chips may need 3-5x the substrate of 2026 designs. … Show more

ASE Technology's packaging tightness now extends beyond AI to analog and mature-node chips, supporting price hikes. Lead times are up over 30%; FC/Wirebond/QFN hikes of 10–80% and CoWoS hikes of 10–20% are expected in 3Q–4Q26. Higher AMD server CPU wafer allocation, CoWoS adoption for Venice, Verano and future AMD CPUs, and limited competition support LEAP growth. LEAP revenue is forecast at US$4bn/$8bn in 2026/27, above guidance. The target rises to NT$843 from NT$754 on 25x 2027E EPS. x.com 

ABF substrates are among the biggest constraints on AI hardware in 2027, a bottleneck that favors Ibiden and Unimicron. Nvidia or Google can cut HBM per GPU or DRAM per server to ship more, but they cannot work around shortages of ABF substrates and PCB/CCL. x.com 

Ibiden is overpriced and set to lose market share, so AT&S, Kinsus and Ajinomoto are the better substrate positions. This runs against FundaAI (@FundaAI), which argues that high-end ABF capacity is failing to keep pace with AI silicon and sees rerating room for Ibiden at about 45 times FY3/28 earnings. x.com